{"top_spans": [[0, 0], [1, 1], [8, 8], [13, 13], [15, 15], [16, 16], [18, 18], [20, 20], [20, 21], [23, 23], [25, 27], [25, 29], [33, 37], [36, 37], [39, 39], [39, 46], [43, 43], [46, 46], [48, 50], [51, 51], [52, 56], [54, 56], [54, 59], [54, 60], [58, 60], [62, 62], [63, 64], [66, 66], [68, 70], [68, 73], [74, 74], [75, 75], [76, 77], [76, 82], [83, 83], [90, 90]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 10, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["abbvie", "expects", "double", "-", "digit", "earnings", "growth", "in", "2019", "nov", "2-", "abbvie", "inc", "said", "on", "friday", "it", "was", "confident", "that", "its", "earnings", "would", "grow", "in", "the", "double", "digits", "in", "2019", "in", "spite", "of", "the", "launch", "of", "biosimilar", "versions", "of", "its", "best", "-", "selling", "rheumatoid", "arthritis", "drug", "humira", "in", "the", "european", "union", "continued", "momentum", "of", "u", "s", "business", "and", "new", "product", "launches", "will", "allow", "the", "drugmaker", "to", "grow", "through", "the", "biosimilar", "impact", "in", "2019", "abbvie", "pancho", "gonzales", "u", "s", "abbvie", "inc", "manas", "mishra", "reuters", "shailesh", "kuber", "richard", "gonzalez", "chief", "executive", "officer", "european", "union"], "clusters": [[[16, 16], [20, 20], [39, 39]], [[39, 46], [63, 64]]]}